Nicholas W Bateman

PhD

Department of Primary Appointment:
School of Medicine
Gynecologic Surgery and Obstetrics
Title
Associate Professor, Department of Gynecologic Surgery and Obstetrics, School of Medicine. Associate Director, Gynecologic Cancer Center of Excellence.
Location: Walter Reed National Military Medical Center, Bethesda, MD
Research Interests:
Gynecologic Oncology, Proteomics, Mass Spectrometry, Bioinformatics, Cell and Molecular Cancer Biology
Office Phone

Education

BS in Biological Sciences. SUNY at Buffalo. Buffalo, NY (1997-2002)
PhD in Molecular Pharmacology. University of Pittsburgh School of Medicine. Pittsburgh, PA (2006-2010)
Postdoctoral Fellowship in Cell Biology and Molecular Physiology. University of Pittsburgh School of Medicine. Pittsburgh, PA (2010-2012)

Biography

I am currently the Associate Director of the Gynecologic Cancer Center of Excellence and an Associate Professor in the Department of Gynecologic Surgery and Obstetrics at Uniformed Services University of the Health Sciences. My training has been focused on basic cell and molecular cancer research as well as application and development of analytical mass spectrometry-based proteomics and bioinformatic approaches to support multi-omic analyses of human tissues and proximal biofluids. I have applied this training throughout my scientific career to basic, translational, and clinical research investigations focused on defining relationships between the human proteome, genome and disease. My current research is focused on refining sample preparation and informatics strategies to support multiomic analyses of human tissues leveraging cutting-edge histopathologic techniques such as laser microdissection microscopy with an emphasis on defining molecular drivers underlying disease etiology and progression and multidrug resistance to improve the therapeutic management of patients diagnosed with gynecologic cancer. My personal scientific goal is to leverage high-throughput proteomics and orthogonal multi-omic approaches to define mechanistic biology that is central to disease pathogenesis and translate these findings to the clinic as refined diagnostic methods and therapeutic approaches that will improve the clinical management of cancer and human disease as a whole.